Suven Life Sciences Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 7.93 | 11.09 | 8.30 |
| Operating Expense | 21.55 | 24.58 | 17.72 |
| Net Profit | -16.38 | -16.12 | -11.17 |
| Net Profit Margin | -206.56% | -145.36% | -134.58% |
| Earning Per Share | -0.58 | -0.61 | -0.50 |
| EBIDTA | -13.62 | -13.48 | -9.43 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Sep 2026
Revenue7.93
Operating Expense21.55
Net Profit-16.38
Net Profit Margin-206.56
Earning Per Share-0.58
EBIDTA-13.62
Effective Tax Rate-0
